Tetra Radar · Company Timeline
Relmada Therapeutics Inc (RLMD)
Sector: Health Care
Earlier observations
- · Insider purchase. Chief Financial Officer Maged Shenouda purchased 200,000 shares at an average price of $4.2199, approximately $843,990 in total.
- · Insider purchase. Chief Executive Officer Sergio Traversa purchased 200,000 shares at an average price of $4.14, approximately $828,000 in total.
Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.
Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.